Forward Management LLC reduced its position in Cooper Companies, Inc. (The) (NYSE:COO) by 1.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,011 shares of the medical device company’s stock after selling 22 shares during the period. Forward Management LLC’s holdings in Cooper Companies, Inc. (The) were worth $482,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of COO. YorkBridge Wealth Partners LLC raised its position in Cooper Companies, Inc. (The) by 18.5% in the first quarter. YorkBridge Wealth Partners LLC now owns 520 shares of the medical device company’s stock worth $105,000 after buying an additional 81 shares during the last quarter. Archford Capital Strategies LLC raised its position in Cooper Companies, Inc. (The) by 116.7% in the first quarter. Archford Capital Strategies LLC now owns 674 shares of the medical device company’s stock worth $135,000 after buying an additional 363 shares during the last quarter. Penserra Capital Management LLC raised its position in Cooper Companies, Inc. (The) by 9.5% in the first quarter. Penserra Capital Management LLC now owns 782 shares of the medical device company’s stock worth $156,000 after buying an additional 68 shares during the last quarter. Pacer Advisors Inc. raised its position in Cooper Companies, Inc. (The) by 3.8% in the first quarter. Pacer Advisors Inc. now owns 848 shares of the medical device company’s stock worth $170,000 after buying an additional 31 shares during the last quarter. Finally, Visionary Asset Management Inc. bought a new position in Cooper Companies, Inc. (The) during the second quarter worth approximately $201,000. 99.97% of the stock is owned by hedge funds and other institutional investors.

Shares of Cooper Companies, Inc. (COO) opened at 240.92 on Friday. The company has a market cap of $11.77 billion, a price-to-earnings ratio of 36.12 and a beta of 0.61. The company’s 50-day moving average price is $245.14 and its 200 day moving average price is $214.89. Cooper Companies, Inc. has a 1-year low of $158.73 and a 1-year high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last posted its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 EPS for the quarter, topping the consensus estimate of $2.25 by $0.25. The firm had revenue of $522.40 million during the quarter, compared to analyst estimates of $520.71 million. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. Cooper Companies, Inc. (The)’s revenue was up 8.0% on a year-over-year basis. During the same period in the prior year, the business posted $2.05 EPS. On average, analysts predict that Cooper Companies, Inc. will post $9.63 earnings per share for the current fiscal year.

The firm also recently declared a semiannual dividend, which was paid on Monday, August 7th. Shareholders of record on Friday, July 21st were paid a $0.03 dividend. The ex-dividend date was Wednesday, July 19th. This represents a yield of 0.02%. Cooper Companies, Inc. (The)’s payout ratio is presently 0.90%.

COPYRIGHT VIOLATION NOTICE: “Forward Management LLC Has $482,000 Stake in Cooper Companies, Inc. (The) (COO)” was reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.watchlistnews.com/forward-management-llc-has-482000-stake-in-cooper-companies-inc-the-coo/1477449.html.

COO has been the subject of a number of analyst reports. Zacks Investment Research raised Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $274.00 price target for the company in a report on Friday, June 23rd. Jefferies Group LLC reaffirmed a “buy” rating and issued a $250.00 price target (up from $220.00) on shares of Cooper Companies, Inc. (The) in a report on Saturday, June 3rd. Stifel Nicolaus raised their price target on Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the stock a “buy” rating in a report on Friday, June 2nd. BMO Capital Markets reaffirmed a “buy” rating and issued a $255.00 price target on shares of Cooper Companies, Inc. (The) in a report on Thursday, July 13th. Finally, BidaskClub lowered Cooper Companies, Inc. (The) from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Cooper Companies, Inc. (The) has a consensus rating of “Buy” and an average target price of $242.00.

In other Cooper Companies, Inc. (The) news, EVP Carol R. Kaufman sold 44,092 shares of the stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $242.81, for a total value of $10,705,978.52. Following the completion of the sale, the executive vice president now owns 60,419 shares in the company, valued at approximately $14,670,337.39. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Paul L. Remmell sold 9,294 shares of the stock in a transaction on Friday, July 14th. The stock was sold at an average price of $248.46, for a total value of $2,309,187.24. Following the completion of the sale, the chief executive officer now owns 6,186 shares of the company’s stock, valued at approximately $1,536,973.56. The disclosure for this sale can be found here. Insiders sold a total of 67,331 shares of company stock valued at $16,400,454 in the last quarter. 1.60% of the stock is currently owned by company insiders.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.